1. European biotechs match gains in US market

    Interviewee/Contributer: William Ellington

    Organisation: MedNous

    Read more

  2. Small molecules or biologics: that's the question

    Interviewee/Contributer: Jean-Claude Muller

    Organisation: Innovation and International Relationship

    Read more

  3. The inventive step: antibody-drug conjugates

    Interviewee/Contributer: John Lambert

    Organisation: ImmunoGen Inc

    Read more

  4. 10-year oncology review: innovation accelerates

    Interviewee/Contributer: Bruno Pagliara

    Organisation: On-kòs Pharma Consulting

    Read more

  5. OrgaNext pioneers treatment for the elderly

    Interviewee/Contributer: Marjanne Prins

    Organisation: OrgaNext Research BV

    Read more

  6. Value-based drug pricing coming soon in UK

    Interviewee/Contributer: Karen Fi nn

    Organisation: MedNous

    Read more

  7. MorphoSys and Heptares explore new targets

    Interviewee/Contributer: Malcolm Weir

    Organisation: Heptares Therapeutics Ltd

    Read more

  8. New role for venture capital in pivotal trials

    Interviewee/Contributer: Genghis Lloyd-Harris

    Organisation: Abingworth LLP

    Read more

  9. JP Morgan - Biotech parades its approvals

    Interviewee/Contributer: Max Herrmann

    Organisation: Consultant

    Read more

  10. A short history of health technology assessment

    Interviewee/Contributer: Jim Furniss

    Organisation: GfK Bridgehead

    Read more